Literature DB >> 23216233

The selection of DNA aptamers for two different epitopes of thrombin was not due to different partitioning methods.

Robert Wilson1, Andrew Cossins, Dan V Nicolau, Sotiris Missailidis.   

Abstract

Nearly all aptamers identified so far for any given target molecule have been specific for the same binding site (epitope). The most notable exception to the 1 aptamer per target molecule rule is the pair of DNA aptamers that bind to different epitopes of thrombin. This communication refutes the suggestion that these aptamers exist because different partitioning methods were used when they were selected. The possibility that selection of these aptamers was biased by conflicting secondary structures was also investigated and found not to contribute. The preparation of protein-coated magnetic beads for systematic evolution of ligands by exponential enrichment (SELEX) and the different specificities of the thrombin aptamers for the α and β forms of thrombin are also reported.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23216233      PMCID: PMC3569956          DOI: 10.1089/nat.2012.0386

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  17 in total

Review 1.  Applications of aptamers as sensors.

Authors:  Eun Jeong Cho; Joo-Woon Lee; Andrew D Ellington
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2009       Impact factor: 10.745

Review 2.  SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.

Authors:  Regina Stoltenburg; Christine Reinemann; Beate Strehlitz
Journal:  Biomol Eng       Date:  2007-06-16

Review 3.  Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy.

Authors:  Michael Famulok; Jörg S Hartig; Günter Mayer
Journal:  Chem Rev       Date:  2007-08-23       Impact factor: 60.622

Review 4.  The chemical biology of aptamers.

Authors:  Günter Mayer
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

5.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin.

Authors:  L C Bock; L C Griffin; J A Latham; E H Vermaas; J J Toole
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

6.  A reliable method for attaching biological molecules to layer-by-layer self-assemblies.

Authors:  Robert Wilson; Maryam Mehrabi; Ian A Prior; Alison Beckett; Alistair Hutchinson
Journal:  Chem Commun (Camb)       Date:  2009-03-31       Impact factor: 6.222

7.  HD1, a thrombin-directed aptamer, binds exosite 1 on prothrombin with high affinity and inhibits its activation by prothrombinase.

Authors:  Colin A Kretz; Alan R Stafford; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2006-10-17       Impact factor: 5.157

8.  A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA.

Authors:  K Y Wang; S McCurdy; R G Shea; S Swaminathan; P H Bolton
Journal:  Biochemistry       Date:  1993-03-02       Impact factor: 3.162

9.  A simple method for preparing spectrally encoded magnetic beads for multiplexed detection.

Authors:  Robert Wilson; David G Spiller; Ian A Prior; Kees J Veltkamp; Alistair Hutchinson
Journal:  ACS Nano       Date:  2007-12       Impact factor: 15.881

10.  Electrochemiluminescence enzyme immunoassays for TNT and pentaerythritol tetranitrate.

Authors:  Robert Wilson; Charles Clavering; Alistair Hutchinson
Journal:  Anal Chem       Date:  2003-08-15       Impact factor: 6.986

View more
  2 in total

1.  Single-step selection of bivalent aptamers validated by comparison with SELEX using high-throughput sequencing.

Authors:  Robert Wilson; Christian Bourne; Roy R Chaudhuri; Richard Gregory; John Kenny; Andrew Cossins
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

2.  Blood clot detection using magnetic nanoparticles.

Authors:  Hafsa Khurshid; Bruce Friedman; Brent Berwin; Yipeng Shi; Dylan B Ness; John B Weaver
Journal:  AIP Adv       Date:  2017-02-16       Impact factor: 1.548

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.